After earnings more than doubled in 2023, analysts expect MercadoLibre's growth to remain strong, up 78% this year.
FOSTER CITY, Calif., June 28, 2024--Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
This biotech stock nears a buy point after an explosive move following positive drug trial news. Sales have grown by triple-digits for seven quarters.